Publikationen von Matthias L. Schroeter
Alle Typen
Zeitschriftenartikel (235)
2015
Zeitschriftenartikel
86 (6), S. 700 - 701 (2015)
Frontomedian cortex is central for moral deficits in behavioural variant frontotemporal dementia. Journal of Neurology, Neurosurgery & Psychiatry
Zeitschriftenartikel
45 (3), S. 224 - 233 (2015)
PET/MR in dementia and other neurodegenerative diseases. Seminars in Nuclear Medicine
Zeitschriftenartikel
29 (3), S. 382 - 387 (2015)
Association of the apolipoprotein E genotype with memory performance and executive functioning in cognitively intact elderly. Neuropsychology
Zeitschriftenartikel
174, S. 432 - 440 (2015)
BDNF as a biomarker for successful treatment of mood disorders: A systematic & quantitative meta-analysis. Journal of Affective Disorders
Zeitschriftenartikel
262 (3), S. 563 - 569 (2015)
Identifying neural correlates of memory and language disturbances in herpes simplex encephalitis - A voxel-based morphometry (VBM) study. Journal of Neurology
Zeitschriftenartikel
47 (4), S. 939 - 954 (2015)
Applying automated MR-based diagnostic methods to the memory clinic: A prospective study. Journal of Alzheimer's Disease
Zeitschriftenartikel
47 (3), S. 539 - 543 (2015)
Alzheimer’s disease FDG PET imaging pattern in an amyloid-negative mild cognitive impairment subject. Journal of Alzheimer's Disease 2014
Zeitschriftenartikel
9 (12), e114206 (2014)
Obesity associated cerebral gray and white matter alterations are interrelated in the female brain. PLoS One
Zeitschriftenartikel
57, S. 22 - 37 (2014)
Conceptualizing neuropsychiatric diseases with multimodal data-driven meta-analyses: The case of behavioral variant frontotemporal dementia. Cortex
Zeitschriftenartikel
34 (7), S. 1091 - 1095 (2014)
Early small vessel disease affects frontoparietal and cerebellar hubs in close correlation with clinical symptoms: A resting-state fMRI study. Journal of Cerebral Blood Flow and Metabolism
Zeitschriftenartikel
53, S. 84 - 86 (2014)
Further evidence for a role of S100B in mood disorders: A human gene expression mega-analysis. Journal of Psychiatric Research
Zeitschriftenartikel
264 (4), S. 311 - 316 (2014)
S100B is downregulated in the nuclear proteome of schizophrenia corpus callosum. European Archives of Psychiatry and Clinical Neuroscience
Zeitschriftenartikel
9, 23 (2014)
Association between mental demands at work and cognitive functioning in the general population – Results of the health study of the Leipzig research center for civilization diseases (LIFE). Journal of Occupational Medicine and Toxicology
Zeitschriftenartikel
42, S. 188 - 198 (2014)
Structural and functional MRI study of the brain, cognition and mood in long-term adequately treated Hashimoto's thyroiditis. Psychoneuroendocrinology
Zeitschriftenartikel
87, S. 170 - 182 (2014)
Impact of image acquisition on voxel-based morphometry investigations of age-related structural brain changes. NeuroImage
Zeitschriftenartikel
152-154, S. 28 - 38 (2014)
Prevalence of minor depression in elderly persons with and without mild cognitive impairment: A systematic review. Journal of Affective Disorders
Zeitschriftenartikel
39, S. 33 - 38 (2014)
Decrease of serum S100B during an oral glucose tolerance test correlates inversely with the insulin response. Psychoneuroendocrinology 2013
Zeitschriftenartikel
27 (8), S. 17 (2013)
Kognitive Funktionsstörungen bei früher zerebraler Mikroangiopathie (Cognitive deficits in early small vessel disease). Neuro aktuell: Informationsdienst für Neurologen & Psychiater
Zeitschriftenartikel
47 (11), S. 1694 - 1699 (2013)
S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: A postmortem study. Journal of Psychiatric Research
Zeitschriftenartikel
14 (11), S. 1237 - 1248 (2013)
Serum S100B represents a new biomarker for mood disorders. Current Drug Targets